Telix Pharmaceuticals Limited (TLX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Telix Pharmaceuticals Lim...

    NASDAQ: TLX · Real-Time Price · USD
    10.28
    0.06 (0.59%)
    At close: Oct 03, 2025, 3:59 PM
    10.28
    0.00%
    After-hours: Oct 03, 2025, 06:06 PM EDT

    Telix Pharmaceuticals Income Statement

    Financials in AUD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Jun 30, 2025 Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 593.11M 594.24M 188.96M 281.71M 220.83M 136.05M 24.05M 4.69M 2.91M
    Cost of Revenue
    		 304.77M 208.45M 65.08M 57.74M 130.02M 91.16M 39.62M 23.54M 14.09M
    Gross Profit
    		 288.34M 385.8M 123.88M 223.97M 90.81M 44.89M -15.57M -18.86M -11.18M
    Operating Income
    		 15.79M 68.38M 13.75M 20.07M 31.44M -9.7M -63.49M -49.92M -31.6M
    Interest Income
    		 n/a 10.25M 610K 566K 453K 214K 1K 89K 74K
    Pretax Income
    		 -7.35M 46.91M 9.14M 15.39M -12.3M -27.92M -70.7M -61.99M -37.05M
    Net Income
    		 -3.48M 38.24M 11.68M 19.53M -14.32M -33.19M -70.89M -48M -32.51M
    Selling & General & Admin
    		 146.92M 111.82M 64.25M 105.5M 28.93M 21.58M 23.08M 10.59M 6.75M
    Research & Development
    		 123.96M 75.25M 45.78M 98.4M 30.45M 33.01M 24.84M 20.46M 13.67M
    Other Expenses
    		 1.68M 130.35M 96K n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 272.56M 317.42M 110.13M 203.9M 59.37M 54.59M 47.92M 31.06M 20.42M
    Interest Expense
    		 n/a 16.52M 4.94M 548K 442K 268K 138K 104K 85K
    Selling & Marketing Expenses
    		 74.41M 48.16M n/a 25.94M 5.6M 27.61M 10.36M 3.5M 2.39M
    Cost & Expenses
    		 577.32M 525.87M 175.21M 261.64M 189.4M 145.75M 87.54M 54.6M 34.51M
    Income Tax Expense
    		 3.87M 8.67M -2.54M -4.14M 2.02M 5.27M 188K -14M -4.53M
    Shares Outstanding (Basic)
    		 337.21M 331.23M 334.23M 323.73M 317.62M 316.34M 307.33M 283.02M 281.02M
    Shares Outstanding (Diluted)
    		 337.2M 345.19M 350.75M 323.73M 317.62M 316.34M 307.33M 283.02M 281.02M
    EPS (Basic)
    		 -0.01 0.12 0.03 0.06 -0.05 -0.1 -0.23 -0.17 -0.12
    EPS (Diluted)
    		 -0.01 0.11 0.03 0.06 -0.05 -0.1 -0.23 -0.17 -0.12
    EBITDA
    		 8.91M 76.8M 40.29M 22.99M 34.72M -7.05M -60.76M -47.29M -28.79M
    EBIT
    		 -1.76M 78.46M 14.09M 20.9M -11.86M -27.65M -70.56M -61.89M -36.69M
    Depreciation & Amortization
    		 10.67M -2M 3.66M 2.09M 3.29M 2.66M 2.74M 2.63M 2.81M

    Add to Watchlist